For the third year, Treatment Action Group (TAG) analyzes and reports on the annual funding of tuberculosis (TB) research and development (R&D). The top 40 TB research funding institutions were surveyed for actual disbursements made for R&D in fiscal years 2005, 2006, and now 2007. three-year data reveal trends in funding and demonstrates an alarming shortfall in the growth of R&during the initial years covered by The Global Plan to Stop TB: 2006–2015.